Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Baylor College of Medicine
Zhejiang University
First Affiliated Hospital Xi'an Jiaotong University
Fox Chase Cancer Center
Emory University
University of Nebraska
Changhai Hospital
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Zhejiang University
Zhejiang University
Northwestern University
Huazhong University of Science and Technology
M.D. Anderson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)